Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
15000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Stock acquisition rights issued through a third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
Number of shares delivered during the month: 15,000,000 shares (15,000,000 new shares; no transfer of treasury shares)
Existing Shares and Increase
+4.43%Rate of increase
383,643,700 shares398,643,700Shares
Exercise ratio subject to exercise restrictions: 4.43% (①15,000,000 shares / ②338,643,700 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month: ¥20.5, ¥21.4, ¥22.4 and ¥25.2 (specific details and floor price under the exercise price adjustment clause: not disclosed)
Number of Stock Acquisition Rights
Total number issued: 796,000 (calculated based on the statement that 150,000 represented 18.84% of the total issued); unexercised as of the end of the month preceding the month under review: 396,000; unexercised as of the end of the month under review: 246,000
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
8 December 2025: Issuance of the 38th stock acquisition rights (with exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Stock acquisition rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 15,000,000 shares (15,000,000 new shares; no transfer of treasury shares) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 4.43% (①15,000,000 shares / ②338,643,700 shares) |
| Total number of issued shares | 383,643,700 shares (as of the end of the month preceding the month under review) → 398,643,700 shares (assuming the number of shares delivered as of the end of the month under review is simply added) |
| Exercise price | Exercise prices during the month: ¥20.5, ¥21.4, ¥22.4 and ¥25.2 (specific details and floor price under the exercise price adjustment clause: not disclosed) |
| Number of Stock Acquisition Rights | Total number issued: 796,000 (calculated based on the statement that 150,000 represented 18.84% of the total issued); unexercised as of the end of the month preceding the month under review: 396,000; unexercised as of the end of the month under review: 246,000 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 8 December 2025: Issuance of the 38th stock acquisition rights (with exercise price adjustment clause) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide notice of the monthly exercise status of the 38th stock acquisition rights in April 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.